Are you looking for access to drug discovery expertise and tools, starting out with an innovative idea and want to learn more about entrepreneurial opportunities or ready to progress towards a start-up or beyond? Join us to hear Dr. Alessia Errico, Associate Director for Search and Evaluation at Cancer Research Horizons, share details of their translational science capabilities, partnerships, investor networks and funding schemes to de-risk projects towards adoption and commercialisation.

Members of the King’s Innovation Catalyst will also be at the webinar and can support with developing an application to (CRH) funding schemes.

Additional information

Cancer Research Horizon funding streams can take you on the next stage of your commercialisation journey whether you want to validate a discovery, licence a dataset or grow a start-up:

Early Detection and Diagnosis Award

Several awards to help develop new techniques, biomarkers and diagnostics to enhance early detection

Up to 4 years

Up to £500k

Therapeutic Catalyst

Early-stage target validation, drug discovery and tech development projects

Up to 1.5 years

Up to £250k

Data Catalyst

Funding to support cleaning, annotation, curation, linking or storage of data with commercial value.

Up to 1 year

Up to £100k

Early Validation Fund

Early-stage project development, proof of concept, patent exemplification

Up to 1 year

Up to £80k

Translation Fund

Gap funding to support translational research and accelerate the journey from lab to market

Up to 1 year

Up to £250k

More information:

Researchers | Cancer Research Horizons

Access funding | Cancer Research Horizons